- Takeda presented nine abstracts at the 62nd ASH Annual Meeting & Exposition, all utilising real-world evidence from the treatment of haemophilia, von Willebrand disease and sickle cell disease
- Takeda are using real-world evidence (RWE) from studies across rare bleeding disorders to demonstrate the crucial role understanding patterns of care play outside of clinical studies play in advancing patient-centric treatment in bleeding disorders
to learn more.
SVMPharma is an innovative strategic consultancy and CRO, with a focus in Real World Evidence (RWE) for pharmaceutical and biotechnology companies. SVMPharma delivers clinical trials within UK and Europe.
DISTILL is a new EDC launched by SVMPharma. As a CRO discover the benefits of DISTILL as part of your service offering and take back control of your clinical trials. DISTILL allows you to develop and manage every aspect of your trials from start to finish. Move away from the restrictions and costs associated with legacy systems.
For more information, please visit www.svmpharma.com
and contact us at email@example.com